Tamron Hall’s Welcome at the 2021 CRI Virtual Immunotherapy Patient Summit

Tamron Hall welcomes attendees to the 2021 CRI Virtual Immunotherapy Patient Summit. #CRIsummit #immunotherapy summit.cancerresearch.org/

00:00- Tamron Hall welcomes everyone
03:49- Jill O’Donnell-Tormey speaks about CRI
05:49- Learn about CRI’s impact

Tamron Hall is an award-winning TV host, journalist and philanthropist. She is the host and executive producer of the daytime television show “Tamron Hall,” which is produced and distributed in national syndication by Walt Disney Television. For her work on the show’s first season, Tamron won the Daytime Emmy for Outstanding Informative Talk Show Host. “Tamron Hall” was also awarded the prestigious Gracie Award in its first season, which recognizes exemplary programming created by women.

Jill O’Donnell-Tormey, Ph.D., is the chief executive officer and director of scientific affairs of the Cancer Research Institute (CRI), a nonprofit organization founded in 1953 that is today the global leader in supporting and coordinating research aimed at harnessing the immune system’s power to conquer all cancers. She joined the organization in 1987 and has been chief executive since 1993. www.cancerresearch.org/about-cri/staff/ceo/jill-o-…

The 2021 CRI Virtual Immunotherapy Patient Summit is part of the Cancer Research Institute's Answer to Cancer Patient Education Program. It was offered free of charge, connecting cancer patients and caregivers with scientific and medical experts. This year’s Summit highlighted the growing implications of immunotherapy for more than 10 cancer types, provided education on the basics of immunotherapy and how clinical trials work, and addressed cancer care disparities. www.cancerresearch.org/en-us/patients/immunotherap…

Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. www.cancerresearch.org/

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.